AC
TELA icon

Armistice Capital’s TELA Bio TELA Stock Holding History

Armistice Capital’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-192,000
Closed -$2.23M – 203
2022
Q1 		$2.23M Sell
192,000
-156,000
-45% -$1.89M 0.04% 97
2021
Q4 		$4.45M Hold
348,000
– – 0.07% 111
2021
Q3 		$4.75M Buy
348,000
+84,000
+32% +$1.17M 0.08% 108
2021
Q2 		$4.25M Buy
264,000
+14,000
+6% +$192K 0.08% 95
2021
Q1 		$3.73M Sell
250,000
-6,000
-2% -$90.3K 0.09% 93
2020
Q4 		$3.85M Buy
256,000
+96,000
+60% +$1.56M 0.13% 87
2020
Q3 		$2.65M Buy
+160,000
New +$2.25M 0.1% 88

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
HLA
Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return

Armistice Capital's TELA Position: Q2 2022 in Review

Armistice Capital sold out of TELA Bio (TELA) in Q2 2022, closing a stake of 192,000 shares — an estimated $2.23M sold.

Armistice Capital first reported a position in TELA in Q3 2020 and held it in 7 quarters. The position peaked at $4.75M in Q3 2021. 32 funds tracked by Wall St. Rank hold TELA as of Q2 2022.

  • Armistice Capital reported no remaining TELA Bio position as of Q2 2022 after selling out during the quarter.
  • Armistice Capital sold 192,000 TELA Bio shares in Q2 2022, an estimated $2.23M.
  • Armistice Capital first reported a position in TELA Bio in Q3 2020 and held it in 7 quarters.
  • Armistice Capital's TELA Bio position peaked at $4.75M in Q3 2021.
  • 32 funds tracked by Wall St. Rank held TELA Bio as of Q2 2022.

Based on Armistice Capital's 13F filing for Q2 2022, filed 15 Aug 2022.